A clinical approach to diagnosis of autoimmune encephalitis
F Graus, MJ Titulaer, R Balu, S Benseler… - The lancet …, 2016 - thelancet.com
Encephalitis is a severe inflammatory disorder of the brain with many possible causes and a
complex differential diagnosis. Advances in autoimmune encephalitis research in the past …
complex differential diagnosis. Advances in autoimmune encephalitis research in the past …
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
Recent biochemical observations have helped redefine antigenic components within the
voltage-gated potassium channel (VGKC) complex. The related autoantibodies may be now …
voltage-gated potassium channel (VGKC) complex. The related autoantibodies may be now …
The clinical spectrum of Caspr2 antibody–associated disease
A van Sonderen, H Ariño, M Petit-Pedrol, F Leypoldt… - Neurology, 2016 - AAN Enterprises
Objective: To report a large cohort of patients with antibodies against contactin-associated
protein-like 2 (Caspr2) and provide the clinical spectrum of this disorder. Methods: Serum …
protein-like 2 (Caspr2) and provide the clinical spectrum of this disorder. Methods: Serum …
Expanded phenotypes and outcomes among 256 LGI 1/CASPR 2‐I g G–positive patients
Objective To describe an expanded phenotypic spectrum and longitudinal outcome in 256
LGI1‐IgG–seropositive and/or CASPR2‐IgG–seropositive patients. Methods Patients were …
LGI1‐IgG–seropositive and/or CASPR2‐IgG–seropositive patients. Methods Patients were …
LGI1 antibody encephalitis: acute treatment comparisons and outcome
A Rodriguez, CJ Klein, E Sechi, E Alden… - Journal of Neurology …, 2022 - jnnp.bmj.com
Objective To compare acute treatment responses and long-term outcome in leucine-rich
glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 …
glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 …
Neurological autoantibody prevalence in epilepsy of unknown etiology
Importance Autoimmune epilepsy is an underrecognized condition, and its true incidence is
unknown. Identifying patients with an underlying autoimmune origin is critical because these …
unknown. Identifying patients with an underlying autoimmune origin is critical because these …
Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
Objective Drug‐resistant seizures are common in patients with leucine‐rich, glioma‐
inactivated 1 (LGI1)‐IgG associated and contactin‐associated protein‐like 2 (CASPR2)‐IgG …
inactivated 1 (LGI1)‐IgG associated and contactin‐associated protein‐like 2 (CASPR2)‐IgG …
Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year
D Dubey, SR Hinson, EA Jolliffe, A Zekeridou… - Journal of …, 2018 - Elsevier
In this prospective evaluation of serum and CSF samples, all but two CSF GFAPα-IgG
positive patients had autoimmune meningoencephalomyelitis while serum GFAPα-IgG …
positive patients had autoimmune meningoencephalomyelitis while serum GFAPα-IgG …
Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology
Movement disorders are a prominent and common feature in many autoantibody-associated
neurological diseases, a group of potentially treatable conditions that can mimic infectious …
neurological diseases, a group of potentially treatable conditions that can mimic infectious …
Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis
V Navarro, A Kas, E Apartis, L Chami, V Rogemond… - Brain, 2016 - academic.oup.com
Encephalitis associated with antibodies against leucine-rich glioma-inactivated 1 (LGI1)
protein is increasingly recognized as an auto-immune disorder associated with …
protein is increasingly recognized as an auto-immune disorder associated with …